کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
5537720 | 1402357 | 2016 | 7 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Challenges and opportunities in RSV vaccine development: Meeting report from FDA/NIH workshop
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
موضوعات مرتبط
علوم زیستی و بیوفناوری
ایمنی شناسی و میکروب شناسی
ایمونولوژی
پیش نمایش صفحه اول مقاله
![عکس صفحه اول مقاله: Challenges and opportunities in RSV vaccine development: Meeting report from FDA/NIH workshop Challenges and opportunities in RSV vaccine development: Meeting report from FDA/NIH workshop](/preview/png/5537720.png)
چکیده انگلیسی
FDA's Center for Biologics Evaluation and Research (CBER) and NIH's National Institute of Allergy and Infectious Diseases (NIAID) organized and co-sponsored an RSV Vaccines Workshop in Bethesda, Maryland on June 1 and 2, 2015. The goal of the conference was to convene scientists, regulators, and industry stakeholders to discuss approaches to RSV vaccine development within the context of three target populations - infants and children, pregnant women, and individuals >60Â years of age. The agenda included topics related to RSV vaccine development in general, as well as considerations specific to each target population, such as clinical and serological endpoints. The meeting focused on vaccine development for high income countries (HIC), because issues relevant to vaccine development for low and middle income countries (LMIC) have been discussed in other forums. This manuscript summarizes the discussion of clinical, scientific, and regulatory perspectives, research gaps, and lessons learned.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Vaccine - Volume 34, Issue 41, 22 September 2016, Pages 4843-4849
Journal: Vaccine - Volume 34, Issue 41, 22 September 2016, Pages 4843-4849
نویسندگان
Jeffrey N. Roberts, Barney S. Graham, Ruth A. Karron, Flor M. Munoz, Ann R. Falsey, Larry J. Anderson, V. Marshall, Sonnie Kim, Judy A. Beeler,